#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	294	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1153	18.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	352	354	ACG	25;25;25	A;C;G	25;25;25	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1547	1549	AGC	34;34;34	A,G;G;C	24,10;34;34	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	1	SNP	p	R234F	1	.	.	700	702	TTC	1022	1024	TTC	59;59;61	T;T;C	59;59;61	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1322	1324	CGT	54;57;56	C;G;T	54;57;56	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	0	HET	.	.	.	C261T	.	261	261	C	583	583	C	70	C,T	43,27	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	0	HET	.	.	.	T999C	.	999	999	T	1321	1321	T	53	T,C	30,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1128	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1836	44.9	0	HET	.	.	.	T180C	.	180	180	T	502	502	T	52	T,C	35,16	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	612	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1787	24.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1517	1519	AAA	14;14;13	A;A;A	14;14;13	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	662	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1910	25.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1387	1389	GAA	40;40;41	G;A;A	40;40;40	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	150	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	834	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	107	G	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	105	C	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	113	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	169	T	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	158	C	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	134	C	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	113	A	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	112	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	105	A	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	94	T	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	96	C	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	101	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	101	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	97	G	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	94	C	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	98	T	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	118	G	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	114	G	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	112	T	110	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	173	T	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	174	G	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	173	C	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	169	A	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	110	C	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	97	C	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	78	A	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	78	A	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	80	G	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	73	C	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	91	T	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	90	G	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	77	T	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	125.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	182	C,G	180,1	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	C990G	SNP	990	990	C	59	59	G	47	G	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	T1002A	SNP	1002	1002	T	71	71	A	42	A	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	A1004G	SNP	1004	1004	A	73	73	G	42	G	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	C1011T	SNP	1011	1011	C	80	80	T	41	T	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	C1023A	SNP	1023	1023	C	92	92	A	49	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	T1024A	SNP	1024	1024	T	93	93	A	50	A	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	T1041G	SNP	1041	1041	T	110	110	G	45	G	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.3	183	43.9	0	.	n	.	0	A1042T	SNP	1042	1042	A	111	111	T	46	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	C990G	SNP	990	990	C	58	58	G	27	G	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	T1002A	SNP	1002	1002	T	70	70	A	26	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	A1003C	SNP	1003	1003	A	71	71	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	G1008C	SNP	1008	1008	G	76	76	C	22	C	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	C1011T	SNP	1011	1011	C	79	79	T	19	T	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	T1012C	SNP	1012	1012	T	80	80	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	C1023A	SNP	1023	1023	C	90	90	A	21	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	.1025G	INS	1025	1025	T	93	93	G	23	G	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	109	109	G	25	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1842	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c17.ctg.4	183	26.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	110	110	T	24	T	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	446	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1443	22.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	197	199	CGT	15;15;16	C;G;T	15;15;16	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	446	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1443	22.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1040	1042	GGC	21;21;21	G;G;C	21;21;21	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	722	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2114	25.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	254	256	AGC	14;14;14	A;G;C	14;14;14	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	722	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2114	25.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	656	658	CTA	26;27;27	C;T;A	25;26;26	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	722	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2114	25.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1175	1177	CAA	28;28;28	C;A;A	28;28;28	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	722	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2114	25.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1274	1276	GGT	53;53;54	G;G;T	53;53;53	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	722	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2114	25.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1844	1846	GTT	24;25;25	G;T;T	24;25;25	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	290	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1359	14.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	493	495	GAA	14;14;14	G;A;A	14;14;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	290	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1359	14.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	673	675	ACC	10;10;10	A;C;C	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	290	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1359	14.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	793	795	ACT	8;8;8	A;C;T	8;8;8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	290	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1359	14.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1183	1185	ATC	14;13;12	A;T;C	14;13;12	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	452	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1367	24.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1340	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3501	28.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	496	498	ATC	30;30;28	A;T;C	30;30;28	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1340	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3501	28.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2209	2211	AAG	27;27;28	A;A;G	27;27;28	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	452	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1619	20.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	259	261	GTC	12;12;11	G;T;C	12;12;11	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	452	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1619	20.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1000	1002	TGC	29;30;29	T;G;C	29;30;29	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	426	426	T	28	T	28	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	732	734	GAC	34;33;34	G;A;C	34;33;33	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1008	1010	TTA	22;23;23	T;T;A	22;23;23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2085	2087	AAT	23;23;23	A;A;T	23;23;23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2199	2201	AGT	33;32;31	A;G;T	33;32;31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2598	2600	GTG	25;24;24	G;T;G	25;24;24	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1236	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3568	25.7	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3153	3155	AAG	22;22;22	A;A;G	22;22;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	242	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1075	16.3	1	SNP	p	R45C	0	.	.	133	135	CGC	335	337	CGC	26;26;26	C;G;C	25;25;25	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	254	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1126	16.7	0	.	p	.	0	L34F	NONSYN	100	102	CTC	242	244	TTC	25;25;26	T;T;C	25;25;26	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	254	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1126	16.7	0	.	p	.	0	E122G	NONSYN	364	366	GAG	506	508	GGG	26;26;26	G;G;G	26;26;26	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	272	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1179	17.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	631	633	CTT	31;31;31	C;T;T	31;31;30	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1346	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3151	31.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2136	2138	GCA	35;36;36	G;C;A	35;35;36	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1346	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3151	31.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2397	2399	ACC	34;34;35	A;C;C	33;33;34	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1346	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3151	31.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2706	2708	GCC	38;37;38	G;C;C	38;37;38	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	302	304	GCT	18;18;18	G;C;T	17;18;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	422	424	GAG	20;21;22	G;A;G	20;21;22	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	458	460	TGC	20;19;20	T;G;C	20;19;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	641	643	GTT	26;25;27	G;T;T	26;25;27	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	791	793	CAC	29;28;29	C;A;C	29;27;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1076	1078	ATG	26;26;26	A;T;G	26;26;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	672	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2380	20.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2072	2074	CGC	22;22;21	C;G;C	22;22;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	334	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1051	23.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	807	809	ACC	17;17;17	A;C;C	17;17;17	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	334	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1051	23.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	819	821	TCG	20;21;21	T;C;G	20;21;21	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	280	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1341	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	438	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1900	16.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1318	1320	AAA	11;11;12	A;A;A	11;11;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	438	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1900	16.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1330	1332	GAG	10;10;10	G;A;G	10;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	438	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1900	16.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1336	1338	CAC	8;8;8	C;A;C	8;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	438	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1900	16.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1390	1392	GAG	16;16;16	G;A;G	16;16;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	27	366	TEM_1+	861	861	100.0	TEM_1+.l15.c4.ctg.1	1361	20.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	586	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1747	24.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	352	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1323	19.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	312	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1386	16.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA8.3002863.KJ174469.710_1220.568	dfrA8.3002863.KJ174469.710_1220.568	1	0	27	272	dfrA8	510	510	100.0	dfrA8.l15.c4.ctg.1	1113	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA8 is a transposon-encoded dihydrofolate reductase found in Salmonella enterica;dfrA8
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	426	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1541	20.2	0	.	p	.	0	W42C	NONSYN	124	126	TGG	327	329	TGT	22;22;21	T;G;T,G	22;22;20,1	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	426	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1541	20.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	858	860	GTC	36;36;36	G;T;C	36;36;36	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	730	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	1930	27.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	524	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1767	22.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	889	891	AGC	33;33;32	A;G;C	33;33;32	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	16	emrE_1	333	191	95.29	emrE_1.l6.c4.ctg.1	257	3.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	388	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1577	18.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	761	763	AGG	21;21;21	A;G;G	21;21;21	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	388	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1577	18.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1151	1153	GAC	17;17;17	G;A;C	17;17;17	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	224	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1076	15.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	538	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1980	19.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	194	evgA	615	615	99.19	evgA.l15.c4.ctg.1	901	15.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	216	218	CTG	19;21;21	C;T;G	18;21;20	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	334	336	ATA	16;16;14	A;T;A	16;16;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	346	348	GTA	15;15;15	G;T;A	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	499	501	ACG	20;20;20	A;C;G	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	562	564	GAA	14;14;13	G;A;A	14;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	601	603	GCT	22;22;20	G;C;T	22;22;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	619	621	GAT	20;20;20	G;A;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	706	708	TCA	14;13;14	T;C;A	14;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	835	837	CAG	10;10;12	C;A;G	10;10;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	973	975	GTT	20;20;20	G;T;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1129	1131	GAT	16;16;16	G;A;T	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1297	1299	AAT	7;7;8	A;A;T	7;7;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1318	1320	TTA	6;8;8	T;T;A	6;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1519	1521	AAA	10;10;9	A;A;A	10;10;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2254	2256	CAT	21;21;21	C;A;T	21;20;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2308	2310	CAT	16;16;15	C;A;T	16;16;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2326	2328	AGA	9;9;9	A;G;A	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2341	2343	AAT	11;12;11	A;A;T	11;12;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2488	2490	TCC	24;23;22	T;C;C	23;23;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2653	2655	ATT	15;14;13	A;T;T	15;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2674	2676	GAT	15;16;16	G;A;T	15;16;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2788	2790	GTT	15;16;14	G;T;T	15;16;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	996	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4092	18.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3073	3075	CAC	22;23;23	C;A;C	22;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	348	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1487	17.3	1	SNP	p	P64A	0	.	.	190	192	CCA	485	487	CCA	29;28;29	C;C;A	29;28;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	348	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1487	17.3	1	SNP	p	P64L	0	.	.	190	192	CCA	485	487	CCA	29;28;29	C;C;A	29;28;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	348	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1487	17.3	1	SNP	p	P64H	0	.	.	190	192	CCA	485	487	CCA	29;28;29	C;C;A	29;28;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	348	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1487	17.3	1	SNP	p	P64S	0	.	.	190	192	CCA	485	487	CCA	29;28;29	C;C;A	29;28;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	348	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1487	17.3	1	SNP	p	P64R	0	.	.	190	192	CCA	485	487	CCA	29;28;29	C;C;A	29;28;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	184	gadE	528	528	100.0	gadE.l15.c17.ctg.1	1301	10.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	375	96.0	gadW.l15.c4.ctg.1	481	10.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	348	350	GCG	11;11;10	G;C;G	11;11;10	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	228	gadX	825	825	97.82	gadX.l6.c4.ctg.1	1266	13.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	396	398	TTA	13;12;12	T;T;A	13;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	228	gadX	825	825	97.82	gadX.l6.c4.ctg.1	1266	13.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	474	476	ATT	19;19;19	A;T;T	19;19;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	228	gadX	825	825	97.82	gadX.l6.c4.ctg.1	1266	13.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	975	977	GGA	13;13;13	G;G;A	13;13;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	228	gadX	825	825	97.82	gadX.l6.c4.ctg.1	1266	13.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	981	983	CCG	12;12;12	C;C;G	12;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2233	2235	GAA	29;28;28	G;A;A	28;26;27	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	S83L	0	.	.	247	249	TCG	448	450	TCG	34;34;35	T;C;G	34;34;35	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	S83W	0	.	.	247	249	TCG	448	450	TCG	34;34;35	T;C;G	34;34;35	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	S83I	0	.	.	247	249	TCG	448	450	TCG	34;34;35	T;C;G	34;34;35	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	460	462	GAC	39;39;37	G;A;C	39;39;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	D87G	0	.	.	259	261	GAC	460	462	GAC	39;39;37	G;A;C	39;39;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	D87V	0	.	.	259	261	GAC	460	462	GAC	39;39;37	G;A;C	39;39;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	D87H	0	.	.	259	261	GAC	460	462	GAC	39;39;37	G;A;C	39;39;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1110	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3128	26.3	1	SNP	p	D87N	0	.	.	259	261	GAC	460	462	GAC	39;39;37	G;A;C	39;39;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136H	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136S	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136C	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136L	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136G	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136E	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	978	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2974	24.3	1	SNP	p	R136I	0	.	.	406	408	CGC	664	666	CGC	26;25;25	C;G;C	26;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	214	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1049	14.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	528	530	CCG	19;19;19	C;C;G	19;19;19	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	214	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1049	14.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	681	683	GCC	14;14;14	G;C;C	13;13;14	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	344	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1384	18.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	192	194	TCA	16;16;16	T;C;A	16;16;16	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	194	marA	384	384	99.74	marA.l15.c17.ctg.1	748	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	505	507	AGC	11;11;11	A;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	607	609	CAT	10;9;9	C;A;T	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	V45E	0	.	.	133	135	GTG	331	333	GTG	16;16;17	G;T;G	16;16;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	I49S	0	.	.	145	147	ATC	343	345	ATC	19;19;18	A;T;C	19;19;18	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	A70T	0	.	.	208	210	GCA	406	408	GCA	20;20;20	G;C;A	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R73S	0	.	.	217	219	CGT	415	417	CGT	16;16;16	C;G;T	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R73C	0	.	.	217	219	CGT	415	417	CGT	16;16;16	C;G;T	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R77L	0	.	.	229	231	CGC	427	429	CGC	17;17;17	C;G;C	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R77C	0	.	.	229	231	CGC	427	429	CGC	17;17;17	C;G;C	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	L78M	0	.	.	232	234	CTG	430	432	CTG	17;16;16	C;T;G	17;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R94S	0	.	.	280	282	CGC	478	480	CGC	9;10;10	C;G;C	9;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	R94H	0	.	.	280	282	CGC	478	480	CGC	9;10;10	C;G;C	9;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	936	9.2	1	SNP	p	V96E	0	.	.	286	288	GTA	484	486	GTA	11;11;11	G;T;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	169	171	TTC	11;11;11	T;T;C	10;10;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	256	258	ATC	9;8;9	A;T;C	9;8;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	274	276	GCC	7;7;7	G;C;C	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	277	279	GTG	8;9;9	G;T;G	8;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	304	306	GAT	9;9;9	G;A;T	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	325	327	ACC	10;12;12	A;C;C	10;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	352	354	TTA	11;11;10	T;T;A	11;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	390	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1632	17.8	0	.	p	.	0	G88fs	FSHIFT	262	262	G	412	412	G	10	G	10	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	354	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1838	14.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	308	308	G	15	G	15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	354	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1838	14.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	365	367	CAG	8;9;9	C;A;G	8;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	354	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1838	14.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	515	517	ATC	9;9;9	A;T;C	9;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	354	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1838	14.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	563	565	ATG	13;14;13	A;T;G	13;14;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	354	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1838	14.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	656	658	ACC	13;13;14	A;C;C	13;13;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1983	1985	ACC	23;22;22	A;C;C	23;22;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2376	2378	CAA	17;18;19	C;A;A	17;18;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2544	2546	ATT	23;23;22	A;T;T	23;23;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2628	2630	GTT	23;24;24	G;T,C;T	23;23,1;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2736	2738	GAG	23;25;25	G;A;G	23;25;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2964	2966	ATG	26;25;25	A;T;G	26;25;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1250	mdtB	3123	3123	98.94	mdtB.l6.c17.ctg.1	3542	26.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3099	3101	GAT	35;35;36	G;A;T	35;35;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1162	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3621	23.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	352	354	ATG	15;15;15	A;T;G	14;14;14	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1162	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3621	23.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	838	840	ATC	27;27;26	A;T;C	26;27;25	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1162	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3621	23.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3154	3156	CAC	8;8;8	C;A;C	7;7;6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	612	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1882	24.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	222	224	GAA	16;16;16	G;A;A	16;16;16	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	612	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1882	24.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	891	893	GCG	31;32;34	G;C;G	31;32;34	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	612	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1882	24.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1233	1235	ATC	34;34;34	A;T;C	34;34;33	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	612	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1882	24.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1536	1538	TTT	25;25;25	T;T;T	25;25;25	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	572	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1734	24.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1484	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3708	29.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1222	1224	ACC	32;31;30	A;C;C	31;30;30	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1484	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3708	29.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2464	2466	GAC	31;31;31	G;A;C	30;31;31	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	410	mdtG	1227	1047	99.43	mdtG.l6.c17.ctg.1	1429	16.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	669	671	ATC	17;17;18	A;T;C	17;16;18	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	410	mdtG	1227	182	99.45	mdtG.l6.c17.ctg.2	312	15.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	58	60	GGA	9;10;11	G;G;A	8;9;11	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	466	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1694	20.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	606	608	TGT	23;24;24	T;G;T	22;23;23	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	466	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1694	20.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1176	1178	TTG	25;26;26	T;T;G	25;26;26	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	466	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1694	20.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1386	1388	ACG	10;11;12	A;C;G	10;11;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	524	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1933	20.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	935	937	TCC	15;15;15	T;C;C	14;15;15	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	348	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1452	17.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	509	511	ATT	15;15;14	A;T;T	15;15;14	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	218	220	ATG	15;15;15	A;T;G	15;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	284	286	ATC	19;19;19	A;T;C	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	533	535	CGC	35;34;34	C;G;C	35;34;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	899	901	AGC	19;21;21	A;G;C	19;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1100	1102	GTG	19;19;19	G;T;G	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1163	1165	AAC	24;23;23	A;A;C	23;19;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1208	1210	GTC	25;25;25	G;T;C	25;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1238	1240	ATA	23;22;21	A;T;A	23;22;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1346	1348	TCT	17;18;18	T;C;T	16;18;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1733	1735	GCG	20;20;20	G;C;G	20;20;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2426	24.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1946	1948	ATC	30;30;28	A;T;C	30;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	426	426	T	24	T	24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	609	611	GCG	25;26;25	G;C;G	25;26;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	783	785	ACC	28;28;28	A;C;C	27;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	855	857	CGC	24;22;22	C;G;C	23;22;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	972	974	GCT	26;26;26	G;C;T	25;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1056	1058	AAA	16;14;14	A;A;A	16;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1074	1076	CGA	18;19;19	C;G;A	18;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1239	1241	GCC	18;18;17	G;C;C	18;18;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1251	1253	GAT	20;20;20	G;A;T	20;20;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	478	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1916	18.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1668	1670	GCT	14;14;14	G;C;T	14;13;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3897	25.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1521	1523	AAG	30;30;30	A;A;G	30;29;29	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3897	25.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2598	2600	CTG	35;35;35	C;T;G	35;35;35	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	118	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	648	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	768	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2162	26.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1039	1041	AAC	22;23;24	A;A;C	21;23;23	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	768	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2162	26.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1585	1587	ATA	42;40;40	A;T;A	42;39;39	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	610	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1859	24.3	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1395	1397	GAT	32;31;28	G;A;T	32;31;28	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	610	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1859	24.3	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1398	1400	CTG	29;29;31	C;T;G	29;29;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	297	299	TGT	27;27;27	T;G;T	26;27;27	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	567	569	ACC	18;19;19	A;C;C	18;19;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	777	779	GAC	25;25;25	G;A;C	25;24;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	1	SNP	p	R15C	0	.	.	43	45	CGC	261	263	CGC	41;39;39	C;G;C	41;39;39	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	1	SNP	p	S33R	0	.	.	97	99	AGC	315	317	AGC	30;29;28	A;G;C	30;29;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	1	SNP	p	G131D	0	.	.	391	393	GGC	609	611	GGC	24;25;25	G;G;C	24;25;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	1	SNP	p	R203L	0	.	.	607	609	CGT	825	827	CGT	30;30;29	C;G;T	30;30;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	286	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1242	17.0	1	SNP	p	R203C	0	.	.	607	609	CGT	825	827	CGT	30;30;29	C;G;T	30;30;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	520	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1592	24.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1202	1204	GAG	37;39;39	G;A;G	36;38;38	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	520	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1592	24.1	1	SNP	p	G141D	0	.	.	421	423	GGT	689	691	GGT	34;34;34	G;G;T	34;34;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	520	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1592	24.1	1	SNP	p	G141E	0	.	.	421	423	GGT	689	691	GGT	34;34;34	G;G;T	34;34;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	520	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1592	24.1	1	SNP	p	R154A	0	.	.	460	462	CGT	728	730	CGT	35;35;34	C;G;T	35;35;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	520	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1592	24.1	1	SNP	p	R154D	0	.	.	460	462	CGT	728	730	CGT	35;35;34	C;G;T	35;35;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1086	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2818	28.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1873	1875	TCG	35;36;36	T;C;G	34;36;36	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1086	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2818	28.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2488	2490	AAC	31;31;31	A;A;C	31;31;31	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1086	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2818	28.5	1	SNP	p	A85T	0	.	.	253	255	GCG	502	504	GCG	31;31;32	G;C;G	30;31;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1086	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2818	28.5	1	SNP	p	D111H	0	.	.	331	333	GAT	580	582	GAT	34;34;34	G;A;T	34;34;34	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1086	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2818	28.5	1	SNP	p	S129P	0	.	.	385	387	TCC	634	636	TCC	33;33;34	T;C;C	33;33;34	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	652	parE_1	1893	1893	97.52	parE_1.l15.c17.ctg.1	2413	20.3	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1683	1685	GCT	26;26;26	G;C;T	26;26;26	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003317.NC_003197.3343961_3345854.2094	parE.3003317.NC_003197.3343961_3345854.2094	1	1	16	26	parE_2	1893	113	94.69	parE_2.l6.c4.ctg.2	115	3.3	1	SNP	p	V461G	0	.	.	1381	1383	GTG	108	110	GTG	4;4;4	G;T;G	4;4;4	parE.3003317.NC_003197.3343961_3345854.2094:1:1:V461G:.:Point mutation in Salmonella serovars parE resulting in fluoroquinolones resistance	Salmonella serovars parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	608	patA	1380	1380	99.86	patA.l6.c30.ctg.1	2005	22.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1355	1357	GAT	30;29;28	G;A;T	30;29;28	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	V146F	0	.	.	436	438	GTT	729	731	GTT	26;26;26	G;T;T	26;26;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1830	1832	CAG	40;40;41	C;A;G	40;40;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1830	1832	CAG	40;40;41	C;A;G	40;40;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1869	1871	CAC	29;28;27	C;A;C	29;28;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1878	1880	CGT	26;26;26	C;G;T	26;26;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1878	1880	CGT	26;26;26	C;G;T	26;26;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1884	1886	TCC	29;30;28	T;C;C	29;30;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1890	1892	CTC	27;27;27	C;T;C	27;27;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1980	1982	ACC	26;26;27	A;C;C	25;26;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1983	1985	CCT	27;27;25	C;C;T	27;27;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1782	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4681	28.4	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2352	2354	CGT	56;56;56	C;G;T	56;56;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	.	n	.	0	A226G	SNP	226	226	A	490	490	G	273	G	273	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	A794T	0	.	.	794	794	A	1058	1058	A	254	A	251	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	A794G	0	.	.	794	794	A	1058	1058	A	254	A	251	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	G926A	0	.	.	926	926	G	1190	1190	G	232	G	230	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	G926C	0	.	.	926	926	G	1190	1190	G	232	G	230	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	G926T	0	.	.	926	926	G	1190	1190	G	232	G	230	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	1783	1783	A	215	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	1783	1783	A	215	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	1783	1783	A	215	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	T90C	.	90	90	T	354	354	T	219	T,C	148,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	A250T,G	.	250	250	A	514	514	A	222	A,T,G	167,52,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	G474A	.	474	474	G	738	738	G	214	G,A	158,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	A253T	.	253	253	A	517	517	A	220	A,T	164,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	C194T	.	194	194	C	458	458	C	258	C,T	200,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	G1002A	.	1002	1002	G	1266	1266	G	237	G,A	167,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	G1006C	.	1006	1006	G	1270	1270	G	239	G,C	169,66	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	A79G	.	79	79	A	343	343	A	244	A,G	165,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	C719T	.	719	719	C	983	983	C	279	C,T	171,108	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	T273A	.	273	273	T	537	537	T	221	T,A	167,53	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	T1010C	.	1010	1010	T	1274	1274	T	228	T,C	166,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	C1038T	.	1038	1038	C	1302	1302	C	244	C,T	168,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5716	rrsB+	1542	1542	99.94	rrsB+.l6.c30.ctg.1	2072	200.4	0	HET	.	.	.	C183T	.	183	183	C	447	447	C	257	C,T	166,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	322	soxR	465	465	100.0	soxR.l15.c4.ctg.1	925	25.6	1	SNP	p	R20H	0	.	.	58	60	CGC	286	288	CGC	33;33;33	C;G;C	32;32;32	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	322	soxR	465	465	100.0	soxR.l15.c4.ctg.1	925	25.6	1	SNP	p	G121D	0	.	.	361	363	GGT	589	591	GGT	29;28;28	G;G;T	29;28;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	172	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	962	13.1	1	SNP	p	A12S	0	.	.	34	36	GCA	358	360	GCA	33;33;33	G;C;A	32;32;32	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	354	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l6.c17.ctg.1	1323	19.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	539	366	APH_6__Id+	837	837	99.88	APH_6__Id+.l15.c17.ctg.1	1291	20.7	0	.	p	.	0	E47K	NONSYN	139	141	GAA	385	387	AAA	21;22;22	A;A;A	21;22;22	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	270	sul2	816	816	100.0	sul2.l15.c17.ctg.1	1233	15.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	472	tet-	1206	1206	99.92	tet-.l15.c4.ctg.1	1767	19.9	0	.	p	.	0	T171A	NONSYN	511	513	ACT	823	825	GCT	17;17;17	G;C;T	17;17;17	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	126	tetC	594	594	99.66	tetC.l6.c4.ctg.1	932	9.2	0	.	p	.	0	S152D	NONSYN	454	456	AGT	687	689	GAT	10;9;9	G;A;T	10;9;9	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	228	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	945	16.9	1	SNP	p	H64Y	0	.	.	190	192	CAC	346	348	CAC	15;15;14	C;A;C	15;15;14	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	228	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	945	16.9	1	SNP	p	N82H	0	.	.	244	246	AAT	400	402	AAT	18;20;21	A;A;T	18;20;21	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	228	tetR_1	624	624	100.0	tetR_1.l15.c17.ctg.1	945	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	652	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2036	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
